[go: up one dir, main page]

WO2016190689A3 - Composition permettant de prévenir, de soulager ou de traiter les maladies musculaires ou d'améliorer la fonction musculaire - Google Patents

Composition permettant de prévenir, de soulager ou de traiter les maladies musculaires ou d'améliorer la fonction musculaire Download PDF

Info

Publication number
WO2016190689A3
WO2016190689A3 PCT/KR2016/005597 KR2016005597W WO2016190689A3 WO 2016190689 A3 WO2016190689 A3 WO 2016190689A3 KR 2016005597 W KR2016005597 W KR 2016005597W WO 2016190689 A3 WO2016190689 A3 WO 2016190689A3
Authority
WO
WIPO (PCT)
Prior art keywords
sargassum
composition
fulvellum
extract
fusiforme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2016/005597
Other languages
English (en)
Korean (ko)
Other versions
WO2016190689A2 (fr
Inventor
황재관
김창희
김미보
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Industry Academic Cooperation Foundation of Yonsei University
Original Assignee
Industry Academic Cooperation Foundation of Yonsei University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Industry Academic Cooperation Foundation of Yonsei University filed Critical Industry Academic Cooperation Foundation of Yonsei University
Priority to JP2018514759A priority Critical patent/JP6818018B2/ja
Priority to US15/577,098 priority patent/US10646498B2/en
Priority claimed from KR1020160064917A external-priority patent/KR101809156B1/ko
Publication of WO2016190689A2 publication Critical patent/WO2016190689A2/fr
Publication of WO2016190689A3 publication Critical patent/WO2016190689A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne une composition permettant de prévenir ou traiter des maladies musculaires ou d'améliorer la fonction musculaire, contenant du fucostérol, du Sargassum fulvellum, un produit broyé de Sargassum fulvellum, un extrait de Sargassum fulvellum, du Sargassum fusiforme, un produit broyé de Sargassum fusiforme ou un extrait de Sargassum fusiforme . Selon la présente invention, le fucostérol, le Sargassum fulvellum, un produit broyé de Sargassum fulvellum, un extrait de Sargassum fulvellum, le Sargassum fusiforme, un produit broyé de Sargassum fusiforme ou un extrait de Sargassum fusiforme augmente l'expression de la protéine de p-mTOR, qui est un gène principal impliqué dans la synthèse des protéines musculaires, inhibe l'expression de mARN de MuRF-1 et de l'atrogine-1 impliqués dans la dégradation des protéines musculaires, et augmente l'expression de mARN de MyoD et de myogénine impliqués dans la différenciation musculaire, ce qui a pour effet d'accroître considérablement la fonction musculaire. En outre, étant donné que la composition selon la présente invention est un produit naturel, la composition peut être utilisée en toute sécurité sans effet secondaire, ce qui la rend utilisable en médecine, dans les aliments, les produits cosmétiques, les aliments pour bétail, en tant qu'additif alimentaire et analogue.
PCT/KR2016/005597 2015-05-26 2016-05-26 Composition permettant de prévenir, de soulager ou de traiter les maladies musculaires ou d'améliorer la fonction musculaire Ceased WO2016190689A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2018514759A JP6818018B2 (ja) 2015-05-26 2016-05-26 筋肉疾患の予防、改善または治療用または筋機能改善用組成物
US15/577,098 US10646498B2 (en) 2015-05-26 2016-05-26 Composition for preventing, alleviating or treating muscle diseases or improving muscular function

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR20150072740 2015-05-26
KR10-2015-0072740 2015-05-26
KR10-2016-0064917 2016-05-26
KR1020160064917A KR101809156B1 (ko) 2015-05-26 2016-05-26 퓨코스테롤을 포함하는 근육 질환 예방, 개선 또는 치료용 또는 근 기능 개선용 조성물

Publications (2)

Publication Number Publication Date
WO2016190689A2 WO2016190689A2 (fr) 2016-12-01
WO2016190689A3 true WO2016190689A3 (fr) 2017-01-12

Family

ID=57393558

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2016/005597 Ceased WO2016190689A2 (fr) 2015-05-26 2016-05-26 Composition permettant de prévenir, de soulager ou de traiter les maladies musculaires ou d'améliorer la fonction musculaire

Country Status (1)

Country Link
WO (1) WO2016190689A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107298696A (zh) * 2017-06-22 2017-10-27 舟山富晟食品科技有限公司 羊栖菜活性蛋白的提取方法
WO2019022263A1 (fr) * 2017-07-24 2019-01-31 강릉원주대학교 산학협력단 Préparation pharmaceutique pour traiter la dermatite atopique

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000063617A (ko) * 2000-07-26 2000-11-06 왕종근 한국산 해조류 유래의 면역증강용 추출물 및 그 제조방법
KR20050006533A (ko) * 2003-07-09 2005-01-17 이재화 해조류로부터 항암 및 면역활성 추출물을 추출하는 방법
JP2009191008A (ja) * 2008-02-14 2009-08-27 South Product:Kk 褐藻類由来機能性成分の抽出方法
KR20140060106A (ko) * 2012-11-09 2014-05-19 한국생명공학연구원 해조류 추출물 또는 이의 분획물을 유효성분으로 함유하는 신경보호용 조성물
KR20140081339A (ko) * 2012-12-21 2014-07-01 부경대학교 산학협력단 푸코스테롤을 유효성분으로 포함하는 퇴행성 신경질환 예방 또는 치료용 약제학적 조성물
KR20140131100A (ko) * 2013-05-03 2014-11-12 경희대학교 산학협력단 푸코스테롤을 포함하는 피부 주름 개선 식품, 의약품 및 화장품, 의약품 및 화장품의 조성물

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000063617A (ko) * 2000-07-26 2000-11-06 왕종근 한국산 해조류 유래의 면역증강용 추출물 및 그 제조방법
KR20050006533A (ko) * 2003-07-09 2005-01-17 이재화 해조류로부터 항암 및 면역활성 추출물을 추출하는 방법
JP2009191008A (ja) * 2008-02-14 2009-08-27 South Product:Kk 褐藻類由来機能性成分の抽出方法
KR20140060106A (ko) * 2012-11-09 2014-05-19 한국생명공학연구원 해조류 추출물 또는 이의 분획물을 유효성분으로 함유하는 신경보호용 조성물
KR20140081339A (ko) * 2012-12-21 2014-07-01 부경대학교 산학협력단 푸코스테롤을 유효성분으로 포함하는 퇴행성 신경질환 예방 또는 치료용 약제학적 조성물
KR20140131100A (ko) * 2013-05-03 2014-11-12 경희대학교 산학협력단 푸코스테롤을 포함하는 피부 주름 개선 식품, 의약품 및 화장품, 의약품 및 화장품의 조성물

Also Published As

Publication number Publication date
WO2016190689A2 (fr) 2016-12-01

Similar Documents

Publication Publication Date Title
WO2016190682A3 (fr) Composition pour la prévention et le traitement de maladies musculaires ou pour l'amélioration de la fonction musculaire, contenant de la morusine, du kuwanon g, ou mori cortex radicis
WO2016190683A8 (fr) Composition pour la prévention et le traitement de maladies musculaires ou l'amélioration de la fonction musculaire, contenant un extrait de platycodon grandiflorum
EP4219713A3 (fr) Produits et compositions
EP3862362A3 (fr) Conjugués d'oligonucléotides antisens et leur utilisation pour moduler l'expression de la pkk
MX2017009532A (es) Uso de acidos grasos de cadena corta en prevencion de cancer.
EA201800199A1 (ru) Применение akkermansia muciniphila для лечения метаболических расстройств, увеличения расхода энергии и снижения веса, композиции, лекарственное стедство
SG11201807500RA (en) Agent for increasing intestinal butyric acid and proliferation agent for butyric acid-producing bacteria
PH12017500706A1 (en) Composition containing extract or fraction of genus justicia plant
MX2017007816A (es) Proceso para mejorar porciones y productos musculares.
MY182593A (en) Composition containing chitin and digestible proteins
MY194024A (en) Use of cistanche tubulosa extract and isoacteoside in protection of muscles
WO2016200614A3 (fr) Bactéries modifiées en vue du traitement de maladies associées à l'hyperammoniémie
PH12018500315A1 (en) Fumagillol heterocyclic compounds and methods of making and using same
PH12015502238A1 (en) Neuroprotective effect of carotenoids in brain
MX2018006355A (es) Producto alimenticio para reducir degradacion muscular y metodos del mismo.
MX2017006639A (es) Metodos y composiciones para preservar la masa corporal magra y promover la perdida de grasa durante la perdida de peso.
EP4269587A3 (fr) Modulation de micro-arn contre la dystrophie myotonique de type 1 et antagonistes de micro-arn associés
MX2015014309A (es) Modulador de sabor y metodo para utilizar el mismo.
WO2016190689A3 (fr) Composition permettant de prévenir, de soulager ou de traiter les maladies musculaires ou d'améliorer la fonction musculaire
WO2012108749A3 (fr) Composition et alimentation fonctionnelle pour traiter le cancer du cerveau comprenant un extrait de graines de pharbitis
MX2017013772A (es) Conjugados mezclados de disulfuro de compuestos de tienopiridina y usos de los mismos.
SE1850403A1 (en) Co-crystals
MX2019000846A (es) Preparaciones de vitaminas que contienen galato de propilo.
PH12016501205A1 (en) Catecholamine production accelerator, and therapeutic and preventive agent and therapeutic and preventive food composition for diseases caused by catecholamine deficiency
PH12017500743B1 (en) Tau protein production accelerator, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by tau protein deficiency

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16800328

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2018514759

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 15577098

Country of ref document: US

122 Ep: pct application non-entry in european phase

Ref document number: 16800328

Country of ref document: EP

Kind code of ref document: A2